This user currently has no profile.
A veteran of the pharma industry. Specializing in the analysis of small pharma companies with a focus on the pipeline and opportunities for licensing or major deals with large pharma. Financial analysis including burn rate, venture capital funding, and cash flow.
- Description: Occasional Investor.
- Interests: Bonds, Dividend stock ideas & income, ETFs, Forex, Mutual funds, Options, REITs, Retirement savings, Stocks - long, Stocks - short, Tech stocks
Currently, you have no company profile. Click edit to add a company profile.
Currently, you have no blog details. Click edit to add blog details.
Currently, you have no book details. Click edit to add book details.
Latest Comments more »
- CSYJ,Thanks for you many in... on Gilead: Let's Make A Deal
- BioNoob,I agree, Simtuzumab... on Gilead: Let's Make A Deal
- Touché! Amgen reports filin... on Why I Bought Into Monday's Move In Regeneron
- mghmd,ESPR has an interesti... on Gilead: Let's Make A Deal
- rootbeer,Agree with you 100... on Gilead: Let's Make A Deal